-
1
-
-
0031851293
-
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
-
DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-D
-
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-553. (Pubitemid 28319935)
-
(1998)
Diabetic Medicine
, vol.15
, Issue.7
, pp. 539-553
-
-
Alberti, K.G.M.M.1
Zimmet, P.Z.2
-
2
-
-
75149130955
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
-
(2010)
Diabetes Care
, vol.33
, Issue.SUPPL. 1
-
-
-
4
-
-
84871995815
-
Standards of medical care in diabetes-2013
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
-
(2013)
Diabetes Care
, vol.36
, Issue.SUPPL. 1
-
-
-
5
-
-
64349083605
-
Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006
-
Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122(5):443-453.
-
(2009)
Am J Med
, vol.122
, Issue.5
, pp. 443-453
-
-
Cheung, B.M.1
Ong, K.L.2
Cherny, S.S.3
Sham, P.C.4
Tso, A.W.5
Lam, K.S.6
-
6
-
-
84864870066
-
Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes - National Health and Nutrition Examination Survey, United States, 2007-2010
-
Centers for Disease Control and Prevention (CDC)
-
Ali MK, McKeever Bullard K, Imperatore G, Barker L, Gregg EW; Centers for Disease Control and Prevention (CDC). Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes - National Health and Nutrition Examination Survey, United States, 2007-2010. MMWR Morb Mortal Wkly Rep. 2012;61(suppl):32-37.
-
(2012)
MMWR Morb Mortal Wkly Rep
, vol.61
, Issue.SUPPL.
, pp. 32-37
-
-
Ali, M.K.1
McKeever Bullard, K.2
Imperatore, G.3
Barker, L.4
Gregg, E.W.5
-
7
-
-
13644263258
-
Oral antidiabetic agents: Current role in type 2 diabetes mellitus
-
DOI 10.2165/00003495-200565030-00005
-
Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65(3):385-411. (Pubitemid 40227460)
-
(2005)
Drugs
, vol.65
, Issue.3
, pp. 385-411
-
-
Krentz, A.J.1
Bailey, C.J.2
-
8
-
-
22044439398
-
Oral agents for type 2 diabetes: An update
-
DOI 10.2337/diaclin.23.2.64
-
Kimmel B, Inzucchi SE. Oral agents for type 2 diabetes: an update. Clinical Diabetes. 2005;23(2):64-76. (Pubitemid 40965047)
-
(2005)
Clinical Diabetes
, vol.23
, Issue.2
, pp. 64-76
-
-
Kimmel, B.1
Inzucchi, S.E.2
-
9
-
-
33845472504
-
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
-
DOI 10.2337/dc06-0703
-
Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE; Sitagliptin Study 021 Group. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care. 2006;29(12):2632-2637. (Pubitemid 44912190)
-
(2006)
Diabetes Care
, vol.29
, Issue.12
, pp. 2632-2637
-
-
Aschner, P.1
Kipnes, M.S.2
Lunceford, J.K.3
Sanchez, M.4
Mickel, C.5
Williams-Herman, D.E.6
-
10
-
-
33845476757
-
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
-
DOI 10.2337/dc06-0706
-
Charbonnel B, Karasik A, Liu J, Wu M, Meininger G; Sitagliptin Study 020 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. Diabetes Care. 2006;29(12):2638-2643. (Pubitemid 44912191)
-
(2006)
Diabetes Care
, vol.29
, Issue.12
, pp. 2638-2643
-
-
Charbonnel, B.1
Karasik, A.2
Liu, J.3
Wu, M.4
Meininger, G.5
-
11
-
-
0033578476
-
Pharmacologic therapy for type 2 diabetes mellitus
-
DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131(4):281-303. (Pubitemid 29383658)
-
(1999)
Annals of Internal Medicine
, vol.131
, Issue.4
, pp. 281-303
-
-
DeFronzo, R.A.1
-
12
-
-
84878784631
-
-
Lincolnshire, IL: Takeda Pharmaceuticals America, Inc
-
Actos [package insert]. Lincolnshire, IL: Takeda Pharmaceuticals America, Inc; 2011.
-
(2011)
Actos [Package Insert]
-
-
-
13
-
-
1842516705
-
Type 2 diabetes mellitus
-
Larsen PR et al, eds. Philadelphia, PA: WB Saunders
-
Buse JB, Polonsky KS, Burant CF. Type 2 diabetes mellitus. In: Larsen PR et al, eds. Williams Textbook of Endocrinology. 10th ed. Philadelphia, PA: WB Saunders; 2003:1427-1483.
-
(2003)
Williams Textbook of Endocrinology. 10th Ed.
, pp. 1427-1483
-
-
Buse, J.B.1
Polonsky, K.S.2
Burant, C.F.3
-
14
-
-
77956855349
-
-
Princeton, NJ: Bristol-Myers Squibb
-
Glucophage [package insert]. Princeton, NJ: Bristol-Myers Squibb; 2008.
-
(2008)
Glucophage [Package Insert]
-
-
-
15
-
-
33749871472
-
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes
-
DOI 10.1210/jc.2006-1009
-
Herman GA, Bergman A, Stevens C, et al. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patient with type 2 diabetes. J Clin Endocrinol Metab. 2006;91(11):4612-4619. (Pubitemid 44833446)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.11
, pp. 4612-4619
-
-
Herman, G.A.1
Bergman, A.2
Stevens, C.3
Kotey, P.4
Yi, B.5
Zhao, P.6
Dietrich, B.7
Golor, G.8
Schrodter, A.9
Keymeulen, B.10
Lasseter, K.C.11
Kipnes, M.S.12
Snyder, K.13
Hilliard, D.14
Tanen, M.15
Cilissen, C.16
De Smet, M.17
De Lepeleire, I.18
Van Dyck, K.19
Wang, A.Q.20
Zeng, W.21
Davies, M.J.22
Tanaka, W.23
Holst, J.J.24
Deacon, C.F.25
Gottesdiener, K.M.26
Wagner, J.A.27
more..
-
16
-
-
79951704452
-
Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: A retrospective observational pharmacy claims analysis
-
Garg R, Chen W, Pendergrass M. Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. Diabetes Care. 2010;33(11): 2349-2354.
-
(2010)
Diabetes Care
, vol.33
, Issue.11
, pp. 2349-2354
-
-
Garg, R.1
Chen, W.2
Pendergrass, M.3
-
17
-
-
84877757399
-
The place of GLP-1-based therapy in diabetes management: Differences between DPP-4 inhibitors and GLP-1 receptor agonists
-
Eckerle Mize DL, Salehi M. The place of GLP-1-based therapy in diabetes management: differences between DPP-4 inhibitors and GLP-1 receptor agonists. Curr Diab Rep. 2013;13(3):307-318.
-
(2013)
Curr Diab Rep
, vol.13
, Issue.3
, pp. 307-318
-
-
Eckerle Mize, D.L.1
Salehi, M.2
-
18
-
-
84858225542
-
Novel pharmacological approaches to the treatment of type 2 diabetes
-
Verspohl EJ. Novel pharmacological approaches to the treatment of type 2 diabetes. Pharmacol Rev. 2012;64(2):188-237.
-
(2012)
Pharmacol Rev
, vol.64
, Issue.2
, pp. 188-237
-
-
Verspohl, E.J.1
-
19
-
-
1242272759
-
The sodium/glucose cotransport family SLC5
-
DOI 10.1007/s00424-003-1063-6, The ABCs of Solute Carriers: Physiological, Pathological and Therapeutic Implications of Human Membrane Transport Proteins
-
Wright EM, Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004;447:510-518. (Pubitemid 38241437)
-
(2004)
Pflugers Archiv European Journal of Physiology
, vol.447
, Issue.5
, pp. 510-518
-
-
Wright, E.M.1
Turk, E.2
-
20
-
-
0029938022
-
Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes
-
Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol. 1996;270(4, pt 1):G541-G553.
-
(1996)
Am J Physiol
, vol.270
, Issue.4 PART 1
-
-
Thorens, B.1
-
21
-
-
64749099761
-
Glucose control by the kidney: An emerging target in diabetes
-
Marsenic O. Glucose control by the kidney: an emerging target in diabetes. Am J Kidney Dis. 2009;53:875-883.
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 875-883
-
-
Marsenic, O.1
-
22
-
-
0001524988
-
Glucose transport in the renal proximal tubule
-
Windhager EE, ed. New York, NY: Oxford University Press
-
Silverman M, Turner RJ. Glucose transport in the renal proximal tubule. In: Windhager EE, ed. Handbook of Physiology: Renal Physiology. New York, NY: Oxford University Press; 1992:2017-2038.
-
(1992)
Handbook of Physiology: Renal Physiology
, pp. 2017-2038
-
-
Silverman, M.1
Turner, R.J.2
-
23
-
-
84874291673
-
Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
-
Stenlöf K, Cefalu WT, Kim KA, et al. Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise. Diabetes Obes Metab. 2013;15(4):372-382.
-
(2013)
Diabetes Obes Metab
, vol.15
, Issue.4
, pp. 372-382
-
-
Stenlöf, K.1
Cefalu, W.T.2
Kim, K.A.3
-
24
-
-
67049132386
-
Clinical application of incretin-based therapy: Therapeutic potential, patient selection and clinical use
-
Kendall DM, Cuddihy RM, Bergenstal RM. Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. Am J Med. 2009;122(6 suppl):S37-S50.
-
(2009)
Am J Med
, vol.122
, Issue.6 SUPPL.
-
-
Kendall, D.M.1
Cuddihy, R.M.2
Bergenstal, R.M.3
-
25
-
-
84866268783
-
Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
-
American Diabetes Association; European Association for the Study of Diabetes
-
Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Association; European Association for the Study of Diabetes. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-1379.
-
(2012)
Diabetes Care
, vol.35
, Issue.6
, pp. 1364-1379
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
-
26
-
-
79960952161
-
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: Executive summary
-
AACE Task Force for Developing a Diabetes Comprehensive Care Plan
-
Handelsman Y, Mechanick JI, Blonde L, et al; AACE Task Force for Developing a Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract. 2011;17(2):287-302.
-
(2011)
Endocr Pract
, vol.17
, Issue.2
, pp. 287-302
-
-
Handelsman, Y.1
Mechanick, J.I.2
Blonde, L.3
-
27
-
-
84856740961
-
Oral pharmacologic treatment of type 2 diabetes mellitus: A clinical practice guideline from the American College of Physicians
-
Clinical Guidelines Committee of the American College of Physicians
-
Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156(3):218-231.
-
(2012)
Ann Intern Med
, vol.156
, Issue.3
, pp. 218-231
-
-
Qaseem, A.1
Humphrey, L.L.2
Sweet, D.E.3
Starkey, M.4
Shekelle, P.5
-
28
-
-
11844250564
-
Insulin analogues
-
DOI 10.1056/NEJMra040832
-
Hirsch IB. Insulin analogues. N Engl J Med. 2005;352(2):174-183. (Pubitemid 40096614)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.2
, pp. 174-183
-
-
Hirsch, I.B.1
-
29
-
-
27844545747
-
Insulin analogues in children and teens with type 1 diabetes: Advantages and caveats
-
DOI 10.1016/j.pcl.2005.07.010, PII S0031395505001331, Diabetes Mellitus in Children
-
Rachmiel M, Perlman K, Daneman D. Insulin analogues in children and teens with type 1 diabetes: advantages and caveats. Pediatr Clin North Am. 2005;52(6):1651-1675. (Pubitemid 41654733)
-
(2005)
Pediatric Clinics of North America
, vol.52
, Issue.6
, pp. 1651-1675
-
-
Rachmiel, M.1
Perlman, K.2
Daneman, D.3
|